RxDoctor Payments Data

Bradley Nelson, DPM

Podiatrist · Clinton, OKNPI 1285634469

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,992 of the $3,227 with a category attached, or 61.7%. 7 manufacturers reported payments, led by Convatec Inc. at 50.6% of the total. 2025 is the largest year on record at $1,656, more than ten times the $41 reported in 2019.

$3,227in general payments, 2019–2025

Across 43 payments — averaging $75.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$2K
  • Organogenesis Inc.$1K
  • Stryker$310
  • Restor3d, Inc.$121
  • Treace Medical Concepts, Inc.$44
  • Smith+Nephew$27
  • plus $14 from 1 others

What the payments were for

  • Travel & lodging$1,23638%
  • Food & beverage$1,99262%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,227 in reported general payments places this provider in the 70th percentile of 54 podiatrist providers in Oklahoma.

See all podiatrist providers in Oklahoma

Medicare billing

Part B allowed, 2024
$3,217,575
Medicare patients
786
Services billed
5,894

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort30$1,574
Gabapentin78$1,006
Pregabalin41$800
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort11$690
Doxycycline Hyclate44$673
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav63$673
Duloxetine Hcl55$480
Diclofenac Sodium39$389
Ammonium Lactate14$235
Naproxen39$190
Methylprednisolone21$150
Levofloxacin15$134
Ciprofloxacin Hcl23$113
Allopurinol12$87

Paid to pharmacies, not to this prescriber.

Other podiatrist in Clinton

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →